Erratum: Hemolytic E. coli promotes colonic tumorigenesis in females (Cancer Research (2016) 76 (2891–2900) DOI: 10.1158/0008-5472.CAN-15-2083);Hemolytic E. coli promotes colonic tumorigenesis in females

Cancer Research

Volumn 76, Issue 10, 2016, Pages 2891-2900

  Jin, Ye ^a   Tang, Senwei ^a   Li, Weilin ^a   Ng, Siew Chien ^a   Chan, Michael W Y ^b   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BIM PROTEIN; BIOLOGICAL MARKER; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HEMOLYSIN; HIF1A PROTEIN, HUMAN; MESSENGER RNA; SLC2A1 PROTEIN, HUMAN;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESCHERICHIA COLI; FECES LEVEL; FEMALE; GENE MUTATION; HEMOLYTIC TYPE I ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STAGING; CELL PROLIFERATION; COLON TUMOR; COMPARATIVE STUDY; DRUG SCREENING; ESCHERICHIA COLI INFECTION; FECES; GENETICS; MALE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOMA; ANIMALS; APOPTOSIS; BCL-2-LIKE PROTEIN 11; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HEMOLYSIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED BALB C; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84971529607     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-19-2442     Document Type: Erratum

References (43)

1. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123-40.
2. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein invitro and are associated with colorectal adenocarcinomas in humans. PLoS One 2009;4:e5517.
3. Choi HJ, Kim J, Do KH, Park SH, Moon Y. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: An invitro implication of infection-linked tumor dissemination. Oncogene 2013;32:4960-9.
4. Nougayrede JP, Homburg S, Taieb F, BouryM, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006;313:848-51.
5. Arthur JC, Perez Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
6. Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D, et al. Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathogens 2013;9:e1003141.
7. Li H, Durbin R. Fast and accurate long-read alignment with Burrows- Wheeler transform. Bioinformatics 2010;26:589-95.
8. Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 2010;11:367.
9. Schneider TD, Stephens RM. Sequence logos: A new way to display consensus sequences. Nucleic Acids Res 1990;18:6097-100.
10. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: A sequence logo generator. Genome Res 2004;14:1188-90.
11. Jin Y, Wu J, Li Y, Cai Z, Huang JD. Modification of the RpoS network with a synthetic small RNA. Nucleic Acids Res 2013;41:8332-40.
12. Bej AK, Steffan RJ, DiCesare J, Haff L, Atlas RM. Detection of coliform bacteria in water by polymerase chain reaction and gene probes. Appl Environ Microbiol 1990;56:307-14.
13. Thaker AI, Shaker A, Rao MS, Ciorba MA. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). J Vis Exp 2012;11:pii:4100.
14. Rakoff Nahoum S, Paglino J, Eslami Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
15. Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol 2014;7:4557-76.
16. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14: 195-206.
17. Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, Glasner A, et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe 2013;14:664-74.
18. Mansson LE, Kjall P, Pellett S, Nagy G, Welch RA, Backhed F, et al. Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli. Infect Immun 2007;75:997-1004.
19. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004;96:99-106.
20. Krogfelt KA, Bergmans H, Klemm P. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichiacoli type 1 fimbriae. Infect Immun 1990;58:1995-8.
21. Wiener Z, Band AM, Kallio P, Hogstrom J, Hyvonen V, Kaijalainen S, et al. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-beta. Proc Natl Acad Sci U S A 2014;111:E2229-36.
22. WolfMJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A, et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012;22:91-105.
23. Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT. Chemokines in human colorectal carcinoma. Anticancer Res 2005;25:3581-4.
24. Cui YM, Jiao HL, Ye YP, Chen CM, Wang JX, Tang N, et al. FOXC2 promotes colorectal cancer metastasis by directly targeting MET. Oncogene 2015;34: 4379-90.
25. Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, et al. Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. Int Surg 2011;96:207-16.
26. Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Fujikawa H, Matsushita K, et al. Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy. Surg Today 2012;42:460-9.
27. Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, et al. GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis. Cancer 1998;83:34-40.
28. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 2001;276:9519-25.
29. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005;202: 654-62.
30. Whelan KA, Caldwell SA, Shahriari KS, Jackson SR, Franchetti LD, Johannes GJ, et al. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Mol Biol Cell 2010;21:3829-37.
31. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ. An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009;37:4587-602.
32. Greenhough A, Wallam CA, Hicks DJ, Moorghen M, Williams AC, Paraskeva C. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene 2010; 29:3398-410.
33. Valeva A, Walev I, KemmerH, Weis S, Siegel I, Boukhallouk F, et al. Binding of Escherichia coli hemolysin and activation of the target cells is not receptor-dependent. J Biol Chem 2005;280:36657-63.
34. Troeger H, Richter JF, Beutin L, Gunzel D, Dobrindt U, Epple HJ, et al. Escherichia coli alpha-haemolysin induces focal leaks in colonic epithelium: A novel mechanism of bacterial translocation. Cell Microbiol 2007;9:2530-40.
35. Bucker R, Schulz E, Gunzel D, Bojarski C, Lee IF, John LJ, et al. alpha- Haemolysin of Escherichia coli in IBD: A potentiator of inflammatory activity in the colon. Gut 2014;63:1893-901.
36. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 2004;36:1-12.
37. Uhlen P, Laestadius A, Jahnukainen T, Soderblom T, Backhed F, Celsi G, et al. Alpha-haemolysin of uropathogenic E. coli induces Ca2oscillations in renal epithelial cells. Nature 2000;405:694-7.
38. Yuan G, Nanduri J, Bhasker CR, Semenza GL, Prabhakar NR. Ca2/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 2005;280:4321-8.
39. Azad N, Kathiravelu A, Minoosepeher S, Hebert P, Fergusson D. Gender differences in the etiology of heart failure: A systematic review. JGeriat Card 2011;8:15-23.
40. Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J Leukoc Biol 2012;92:67-73.
41. Webber KM, Perry G, Smith MA, Casadesus G. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Clin Med Res 2007;5:177-83.
42. Roberts CW, Walker W, Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001;14:476-88.
43. Barrat F, Lesourd B, Boulouis HJ, Thibault D, Vincent-Naulleau S, Gjata B, et al. Sex and parity modulate cytokine production during murine ageing. Clin Exp Immunol 1997;109:562-8.